TNF and inflammatory bowel disease: Tumor necrosis factor-α (TNF-α), an inflammatory cytokine released by immune cells, was the target of the first biologics used to treat IBD patients (Laharie et al., 2005; Hyams et al., 2007; Hyams et al., 2012).